Regulus Therapeutics (RGLS) – New Coverage
-
Leerink Partners Starts Regulus Therapeutics (RGLS) at Outperform
-
Canaccord Genuity Starts Regulus Therapeutics (RGLS) at Buy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RGLS Stock Lookup